Free Trial

Chromocell Therapeutics (CHRO) Stock Trends and Sentiment

$0.54 -0.08 (-13.55%)
(As of 11:20 AM ET)

Media Mentions Over Time



View Trending Media Stocks

MarketBeat Searches Over Time

Page Views Over Time



Recieve Chromocell Therapeutics News and Ratings via Email

Sign-up to receive the latest news and ratings for CHRO and its competitors with MarketBeat's FREE daily newsletter.

CHRO Social Media Mentions

Related Companies and Tools


This page (NYSE:CHRO) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners